Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ajem.2022.05.033 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
5-alpha-reductase-inhibitor deferrals: An untapped source of blood donors?
Am J Emerg Med
September 2022
Virtual Our Lady of Lourdes Hospital, 1600 Haddon Ave., Camden, NJ 08103, United States of America.
Blood donors on teratogenic drugs and donor deferral periods in a clinical situation.
Vox Sang
May 2012
Division of Human Blood Safety Surveillance, Korea Centers for Disease Control and Prevention, Osong Health Technology Administration Complex, South Korea.
Deferral of blood donors taking teratogenic drugs is critical. From March 2008 to January 2009, we analysed stored blood specimens from donors who had taken teratogenic drugs and whose blood was transfused to women of childbearing age to determine the plasma concentration at the time of donation using high-performance liquid chromatography. In total, 167 specimens were examined.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!